Does placental transfusion prevent death and disability in very preterm infants? Childhood follow up in the NHMRC Australian Placental Transfusion Study.

胎盘输血能否预防极早产儿的死亡和残疾？

• 批准号: nhmrc : GNT1086865
• 负责人: Prof Kei Lui
• 金额: $ 85.45万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/does-placental-transfusion-transfusion-study/1345682
• 关键词: Does; placental; transfusion; prevent; death

A million babies are born before 30 weeks gestation worldwide each year. Many die or face a lifetime of disability. Enhancing placental transfusion in these infants by deferred clamping of the umbilical cord (DCC) is a simple procedure that may reduce mortality and major disability in childhood. The Australian Placental Transfusion Study (APTS), the largest ever RCT of deferred clamping, will follow up 1200 children born preterm to evaluate if DCC has childhood benefits at 2 years age.

全世界每年有100万婴儿在妊娠30周前出生。许多人死亡或面临终身残疾。在这些婴儿中，通过延迟夹紧脐带（DCC）来加强胎盘输血是一种简单的程序，可以降低儿童期的死亡率和主要残疾。澳大利亚胎盘输血研究（APTS）是有史以来规模最大的延迟钳夹RCT，将随访1200名早产儿，以评估DCC是否对2岁时的儿童有益。